NOVERION LIFE SCIENCES Trademark

Trademark Overview


On Tuesday, March 3, 2026, a trademark application was filed for NOVERION LIFE SCIENCES with the United States Patent and Trademark Office. The USPTO has given the NOVERION LIFE SCIENCES trademark a serial number of 99679694. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, March 3, 2026. This trademark is owned by Noverion Life Sciences Limited. The NOVERION LIFE SCIENCES trademark is filed in the Computer & Software Services & Scientific Services, Personal and Legal & Social Services categories with the following description:

Consultation services in the field of pharmaceutical, biotechnology, and life sciences research and development; consultation services in the field of clinical development, regulatory science, pharmacovigilance, medical research, and evidence generation; consultation services in the field of the design, interpretation, governance, and strategic use of clinical, epidemiological, and observational research; providing information about medical and scientific research; consultation services in the field of pharmacology, drug safety, and regulatory strategy; pharmaceutical research and development; scientific and technological services, namely, research and design in the field of medicine and life sciences; clinical research in the field of pharmaceutical development, pharmacovigilance, and epidemiological and observational research.

Regulatory compliance consulting in the field of pharmaceuticals, biotechnology, and life sciences research and development
noverion life sciences

General Information


Serial Number99679694
Word MarkNOVERION LIFE SCIENCES
Filing DateTuesday, March 3, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, March 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesConsultation services in the field of pharmaceutical, biotechnology, and life sciences research and development; consultation services in the field of clinical development, regulatory science, pharmacovigilance, medical research, and evidence generation; consultation services in the field of the design, interpretation, governance, and strategic use of clinical, epidemiological, and observational research; providing information about medical and scientific research; consultation services in the field of pharmacology, drug safety, and regulatory strategy; pharmaceutical research and development; scientific and technological services, namely, research and design in the field of medicine and life sciences; clinical research in the field of pharmaceutical development, pharmacovigilance, and epidemiological and observational research.
Goods and ServicesRegulatory compliance consulting in the field of pharmaceuticals, biotechnology, and life sciences research and development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 3, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 3, 2026
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNoverion Life Sciences Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC4A 3TW
GB

Trademark Events


Event DateEvent Description
Tuesday, March 3, 2026NEW APPLICATION ENTERED
Tuesday, March 3, 2026APPLICATION FILING RECEIPT MAILED